Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 50 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic modelMoolenaar, L.; Broekmans, F.; van Disseldorp, J.; Fauser, B.; Eijkemans, M.; Hompes, P.; van der Veen, F.; Mol, B.
2011Perinatal risk indicators for long-term neurological morbidity among preterm neonatesTeune, M.; van Wassenaer, A.; van Dommelen, P.; Mol, B.; Opmeer, B.
2011Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidityWilms, F.; Vis, J.; Pattinaja, D.; Kuin, R.; Stam, M.; Reuvers, J.; Mol, B.
2011Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P studyvan Os, M.; van der Ven, J.; Kleinrouweler, C.; Pajkrt, E.; de Miranda, E.; van Wassenaer, A.; Porath, M.; Bossuyt, P.; Bloemenkamp, K.; Willekes, C.; Woiski, M.; Oudijk, M.; Bilardo, K.; Sikkema, M.; Duvekot, J.; Veersema, D.; Laudy, J.; Kuiper, P.; de Groot, C.; Mol, B.; et al.
2011Labour and neonatal outcome in small for gestational age babies delivered beyond 36+0 weeks: a retrospective cohort studyBoers, K.; van der Post, J.; Mol, B.; van Lith, J.; Scherjon, S.
2011Ethnic differences in stillbirth and early neonatal mortality in The NetherlandsRavelli, A.; Tromp, M.; Eskes, M.; Droog, J.; van der Post, J.; Jager, K.; Mol, B.; Reitsma, J.
2011Increasing maternal age at first pregnancy planning: health outcomes and associated costsTromp, M.; Ravelli, A.; Reitsma, J.; Bonsel, G.; Mol, B.
2011Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registryLangenveld, J.; Ravelli, A.; van Kaam, A.; van der Ham, D.; van Pampus, M.; Porath, M.; Mol, B.; Ganzevoort, W.
2011Why were the results of randomized trials on the clinical utility of fetal fibronectin negative? A systematic review of their study designsVis, J.; Wilms, F.; Oudijk, M.; Bossuyt, P.; van der Post, J.; Grobman, W.; Mol, B.
2011Tailored expectant management: risk factors for non-adherencevan den Boogaard, N.; Oude Rengerink, K.; Steures, P.; Bossuyt, P.; Hompes, P.; van der Veen, F.; Mol, B.; van der Steeg, J.